115 filings
Page 3 of 6
8-K
820 s3uy50wd00
2 Nov 22
Other Events
6:07am
DEFA14A
k9f5feoju3s5x2dzna
27 Oct 22
Additional proxy soliciting materials
4:15pm
DEFA14A
skiv yr1dn5j7s90stn
27 Oct 22
Additional proxy soliciting materials
4:11pm
8-K
oycnaxlgdt0q2y90m6t
27 Oct 22
Entry into a Material Definitive Agreement
4:06pm
DEFA14A
mylq0aif9 6qg2tja
21 Oct 22
Additional proxy soliciting materials
7:46am
8-K
2yctpnmx
21 Oct 22
Other Events
7:36am
UPLOAD
o4e ms110y
7 Oct 22
Letter from SEC
12:00am
DEFM14A
okgwq775h9ajvb iugmw
6 Oct 22
Proxy related to merger
4:16pm
8-K
h2uqlyk2r73w44vkmki
30 Sep 22
Entry into a Material Definitive Agreement
4:07pm
PRER14A
a4hc32
16 Sep 22
Preliminary revised proxy
4:56pm
CORRESP
l5gbcq110eplz187y
16 Sep 22
Correspondence with SEC
12:00am
UPLOAD
yermvrz0l 75wfmo40ph
9 Sep 22
Letter from SEC
12:00am
8-K
5tbhl
2 Sep 22
Departure of Directors or Certain Officers
4:05pm
PREM14A
l9qqm0d31codys
11 Aug 22
Preliminary proxy related to merger
5:22pm
DEFA14A
vqomnoiqpdqtmvef3q4
21 Jul 22
Additional proxy soliciting materials
5:05pm
8-K
5mb21qyjpz
21 Jul 22
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
5:01pm
8-K
2k9 du4r779kizobsy0
13 Jun 22
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
2tz30ycht0fgk
12 May 22
Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
4:11pm